Gene · 3357
Papers2,210
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,210
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OpenMMDL - Simplifying the Complex: Building, Simulating, and Analyzing Protein-Ligand Systems in OpenMM. | J Chem Inf Model | 2025 | 39933881 | PubTator, text mining | PubMed |
| Unifying principles for the design and evaluation of natural product-inspired compound collections. | Chem Sci | 2025 | 39906386 | PubTator, text mining | PubMed |
| Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease. | Diabetes Metab J | 2025 | 39905656 | PubTator, text mining | PubMed |
| Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets. | J Nat Prod | 2025 | 39854244 | PubTator, text mining | PubMed |
| Effect of serotonin receptor gene variants on substance use disorders. | Ann Med | 2025 | 39731452 | PubTator, text mining | PubMed |
| The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naïve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission. | Prog Neuropsychopharmacol Biol Psychiatry | 2025 | 39662723 | PubTator, text mining | PubMed |
| Diagnostic value of TRIM22 in diabetic kidney disease and its mechanism. | Endocrine | 2025 | 39509016 | PubTator, text mining | PubMed |
| Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium. | Cardiovasc Pathol | 2025 | 39245153 | PubTator, text mining | PubMed |
| Deficiency of 5-HT2B receptors alleviates atherosclerosis by regulating macrophage phenotype through inhibiting interferon signalling. | Br J Pharmacol | 2025 | 39232850 | PubTator, text mining | PubMed |
| Multiomics-based classifier to decipher immune landscape of uveal melanoma and predict patient outcomes. | J Biomol Struct Dyn | 2025 | 38468495 | PubTator, text mining | PubMed |
| Towards a precision approach to anesthetic/analgesic immunomodulation in cancer. | Front Anesthesiol | 2024 | 40909996 | PubTator, text mining | PubMed |
| Potent and Selective Human 5-HT2B Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic Serendipity. | J Med Chem | 2024 | 39589936 | PubTator, text mining | PubMed |
| Accurate and transferable drug-target interaction prediction with DrugLAMP. | Bioinformatics | 2024 | 39570605 | PubTator, text mining | PubMed |
| Molecular Dynamics (MD) Simulations Provide Insights into the Activation Mechanisms of 5-HT2A Receptors. | Molecules | 2024 | 39459303 | PubTator, text mining | PubMed |
| Mechanism of Mongolian mind-body interactive therapy in regulating essential hypertension through HTR2B: A metabolome- and transcriptome-based study. | Heliyon | 2024 | 39319128 | PubTator, text mining | PubMed |
| Inhibition of HTR2B-mediated serotonin signaling in colorectal cancer suppresses tumor growth through ERK signaling. | Biomed Pharmacother | 2024 | 39255737 | PubTator, text mining | PubMed |
| Therapeutic Potential of 1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline. | Molecules | 2024 | 39202883 | PubTator, text mining | PubMed |
| TORO Indexer: a PyTorch-based indexing algorithm for kilohertz serial crystallography. | J Appl Crystallogr | 2024 | 39108821 | PubTator, text mining | PubMed |
| Pharmacological effects of MT-1207 in bilateral renal artery stenosis hypertension and its hypotensive targets validation. | Biomed Pharmacother | 2024 | 39106710 | PubTator, text mining | PubMed |
| Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited. | J Pharmacol Toxicol Methods | 2024 | 39032441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3357/papers?page=5